Skip to main content

Table 2 Parameters used to describe cases in the dataset

From: Open-access database of literature derived drug-related Torsade de Pointes cases

Parameter Group

Parameter Name

Case ID

unique case identified

Source

author, year, PMID

Patient/population characteristic

age, sex, diseases

Patient’s general health parameters

blood pressure, heart rate, breaths (respiratory rate), temperature

Drugs and alcohol intake

main suspected drug (name, dose, route of administration, additional dosing information, therapeutic range), concomitant drugs (name, dose, route of administration, additional dosing information), overdose (y/n), alcohol

Lab measurements

blood pH, creatinine kinase, blood urea nitrogen, the plasma concentration of: main suspected drug, sodium, potassium, magnesium, calcium, chloride, bicarbonate, lactic acid

ECG parameters

QRS, QT, QTc interval duration

Clinical management and outcome

Applied clinical TdP management, post-intervention QRS, QT/QTc, outcome

Comments

Additional comments

Drug’s properties

SMILES, molecular weight, total polar surface area, logP, H-bond acceptors, H-bond donors, number of rotatable bonds, number of heavy atoms

FDA reports related to the suspected drug

Total number of reports, number of cardiac cases, number of TdP cases, deaths due to TdP